Scaling‐up an evidence‐based intervention for family carers of people with dementia: Current and future costs and outcomes
International Journal of Geriatric Psychiatry · 2024
DOI: 10.1002/gps.6059 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, 2024. Verfasst von Martin Knapp und 6 weiteren Autor:innen. Beteiligte Einrichtung: Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK. Hauptthemen laut MEDLINE: Dementia, Quality of Life. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Thames NIHR Applied Research Collaboration, University College London Hospitals Biomedical Research Centre, National Institute for Health and Care Research.
Themen: Pflegende Angehörige, Demenz
Abstract (Originalsprache)
Objectives
The STrAtegies for RelaTives (START) intervention is effective and cost‐effective in supporting family carers of people with dementia. It is currently not available to all eligible carers in England. What would be the impacts on service costs and carer health‐related quality of life if START was provided to all eligible carers in England, currently and in future?
Methods
Effectiveness and cost‐effectiveness data from a previously conducted randomised controlled trial were combined with current and future projections of numbers of people with newly diagnosed dementia to estimate overall and component costs and health‐related quality of life outcomes between 2015 (base year for projections) and 2040.
Results
Scaling‐up START requires investments increasing annually but would lead to significant savings in health and social care costs. Family carers of people with dementia would experience improvements in mental health and quality of life, with clinical effects lasting at least 6 years. Scaling up the START intervention to eligible carers was estimated to cost £9.4 million in 2020, but these costs would lead to annual savings of £68 million, and total annual quality‐adjusted life year (QALY) gains of 1247. Although the costs of START would increase to £19.8 million in 2040, savings would rise to £142.7 million and Quality adjusted life years gained to 1883.
Conclusions
Scaling‐up START for family carers of people with dementia in England would improve the lives of family carers and reduce public sector costs. Family carers play a vital part in dementia care; evidence‐based interventions that help them to maintain this role, such as START, should be available across the country.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK.
- General Practice, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
- Division of Psychiatry, UCL, London, UK.
ORCID-Profile: Martin Knapp, Raphael Wittenberg
Förderung
- North Thames NIHR Applied Research Collaboration
- University College London Hospitals Biomedical Research Centre
- National Institute for Health and Care Research
- Economic and Social Research Council
Zitieren
APA
Knapp, M., Lorenz-Dant, K., Walbaum, M., Comas-Herrera, A., Cyhlarova, E., Livingston, G., & Wittenberg, R. (2024). Scaling‐up an evidence‐based intervention for family carers of people with dementia: Current and future costs and outcomes. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.6059
Vancouver
Knapp M, Lorenz-Dant K, Walbaum M, Comas-Herrera A, Cyhlarova E, Livingston G, et al. Scaling‐up an evidence‐based intervention for family carers of people with dementia: Current and future costs and outcomes. International Journal of Geriatric Psychiatry. 2024. doi:10.1002/gps.6059
BibTeX
@article{Knapp2024,
author = {Knapp, Martin and Lorenz-Dant, Klara and Walbaum, Magdalena and Comas-Herrera, Adelina and Cyhlarova, Eva and Livingston, Gill and Wittenberg, Raphael},
title = {Scaling‐up an evidence‐based intervention for family carers of people with dementia: Current and future costs and outcomes},
journal = {International Journal of Geriatric Psychiatry},
year = {2024},
doi = {10.1002/gps.6059}
}
EUVIMED